MACROGENICS INC — Director's Dealing 2025

Aug 15, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2025-08-13

Reporting Person: Risser Eric Blasius (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-08-13	Employee Stock Option (right to buy)	$1.66	A	550000	Acquired	2035-08-13	Common Stock (550000)	Direct

Footnotes

F1: 25% of the options will vest and become exercisable one year from the grant date and the remaining 75% will vest in 12 substantially equal quarterly installments thereafter.